These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9458022)

  • 1. Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients.
    Schweitzer EJ; Yoon S; Fink J; Wiland A; Anderson L; Kuo PC; Lim JW; Johnson LB; Farney AC; Weir MR; Bartlett ST
    Transplantation; 1998 Jan; 65(2):242-8. PubMed ID: 9458022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
    Wagner M; Earley AK; Webster AC; Schmid CH; Balk EM; Uhlig K
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007746. PubMed ID: 26633102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mycophenolate mofetil on long-term outcomes in African american renal transplant recipients.
    Meier-Kriesche HU; Ojo AO; Leichtman AB; Punch JD; Hanson JA; Cibrik DM; Kaplan B
    J Am Soc Nephrol; 2000 Dec; 11(12):2366-2370. PubMed ID: 11095660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.
    Ahsan N; Johnson C; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
    Transplantation; 2001 Jul; 72(2):245-50. PubMed ID: 11477347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes.
    David KM; Morris JA; Steffen BJ; Chi-Burris KS; Gotz VP; Gordon RD
    Clin Transplant; 2005 Apr; 19(2):279-85. PubMed ID: 15740568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Neylan JF
    Transplantation; 1997 Nov; 64(9):1277-82. PubMed ID: 9371668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.
    Triemer HL; Pearson TC; Odom KL; Larsen CP
    Clin Transplant; 2000 Aug; 14(4 Pt 2):413-20. PubMed ID: 10946781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
    Odorico JS; Pirsch JD; Knechtle SJ; D'Alessandro AM; Sollinger HW
    Transplantation; 1998 Dec; 66(12):1751-9. PubMed ID: 9884272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group
    Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.
    Knight SR; Russell NK; Barcena L; Morris PJ
    Transplantation; 2009 Mar; 87(6):785-94. PubMed ID: 19300178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW
    Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection.
    Palmer SM; Baz MA; Sanders L; Miralles AP; Lawrence CM; Rea JB; Zander DS; Edwards LJ; Staples ED; Tapson VF; Davis RD
    Transplantation; 2001 Jun; 71(12):1772-6. PubMed ID: 11455257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.
    Merion RM; Henry ML; Melzer JS; Sollinger HW; Sutherland DE; Taylor RJ
    Transplantation; 2000 Jul; 70(1):105-11. PubMed ID: 10919583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients.
    Meier-Kriesche HU; Morris JA; Chu AH; Steffen BJ; Gotz VP; Gordon RD; Kaplan B
    Nephrol Dial Transplant; 2004 Nov; 19(11):2864-9. PubMed ID: 15496562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term use of mycophenolate mofetil is associated with a reduction in the incidence and risk of late rejection.
    Meier-Kriesche HU; Steffen BJ; Hochberg AM; Gordon RD; Liebman MN; Morris JA; Kaplan B
    Am J Transplant; 2003 Jan; 3(1):68-73. PubMed ID: 12492713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil.
    Wüthrich RP; Weinreich T; Ambühl PM; Schwarzkopf AK; Candinas D; Binswanger U
    Nephrol Dial Transplant; 1999 Feb; 14(2):394-9. PubMed ID: 10069195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.